124 related articles for article (PubMed ID: 23683937)
21. [High-dose gynecologic endocavitary brachytherapy. Technical and dosimetric aspects].
Grillo Ruggieri F; Parietti E; Bistolfi F; Tomassini E; Papadia S; Leonardi S; Siragusa A; Guglielmi M; Brizzi C; Scielzo G
Radiol Med; 1989 Oct; 78(4):373-9. PubMed ID: 2595028
[TBL] [Abstract][Full Text] [Related]
22. The Role of Reconstructive Surgery and Brachytherapy in Pediatric Bladder/Prostate Rhabdomyosarcoma.
Schmidt A; Warmann SW; Eckert F; Ellerkamp V; Schaefer J; Blumenstock G; Paulsen F; Fuchs J
J Urol; 2020 Oct; 204(4):825-834. PubMed ID: 32379564
[TBL] [Abstract][Full Text] [Related]
23. Brachytherapy as part of the multidisciplinary treatment of childhood rhabdomyosarcomas of the orbit.
Blank LE; Koedooder K; van der Grient HN; Wolffs NA; van de Kar M; Merks JH; Pieters BR; Saeed P; Baldeschi L; Freling NJ; Koning CC
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1463-9. PubMed ID: 19864080
[TBL] [Abstract][Full Text] [Related]
24. Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX).
de Crevoisier R; Slimane K; Sanfilippo N; Bossi A; Albano M; Dumas I; Wibault P; Fizazi K; Gerbaulet A; Haie-Meder C
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1150-6. PubMed ID: 19395183
[TBL] [Abstract][Full Text] [Related]
25. [Brachytherapy for extremity soft tissue sarcomas].
Delannes M; Thomas L; Brun T; David I; Ducassou A
Cancer Radiother; 2013 Apr; 17(2):151-4. PubMed ID: 23402876
[TBL] [Abstract][Full Text] [Related]
26. Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk.
Crook JM; Potters L; Stock RG; Zelefsky MJ
Brachytherapy; 2005; 4(3):186-94. PubMed ID: 16182218
[TBL] [Abstract][Full Text] [Related]
27. High-dose rate brachytherapy in the treatment of penile carcinoma--first experience.
Petera J; Sirák I; Kašaová L; Mačingová Z; Paluska P; Zouhar M; Kutílek P; Brod'ák M; Vošmik M
Brachytherapy; 2011; 10(2):136-40. PubMed ID: 20702142
[TBL] [Abstract][Full Text] [Related]
28. [Brachytherapy at the Institut Gustave-Roussy: personalized vaginal mould applicator: technical modification and improvement].
Albano M; Dumas I; Haie-Meder C
Cancer Radiother; 2008 Dec; 12(8):822-6. PubMed ID: 18775664
[TBL] [Abstract][Full Text] [Related]
29. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.
Lee LJ; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049
[TBL] [Abstract][Full Text] [Related]
30. [Locally advanced cervical cancer: Should intensity-modulated radiotherapy replace brachytherapy?].
Mazeron R; Gilmore J; Khodari W; Dumas I; Haie-Méder C
Cancer Radiother; 2011 Oct; 15(6-7):477-83. PubMed ID: 21880534
[TBL] [Abstract][Full Text] [Related]
31. Helical tomotherapy delivery of an IMRT boost in lieu of interstitial brachytherapy in the setting of gynecologic malignancy: feasibility and dosimetric comparison.
Gielda BT; Shah AP; Marsh JC; Smart JP; Bernard D; Rotmensch J; Griem KL
Med Dosim; 2011; 36(2):206-12. PubMed ID: 20537887
[TBL] [Abstract][Full Text] [Related]
32. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
[TBL] [Abstract][Full Text] [Related]
33. High dose rate brachytherapy practice for the treatment of gynaecological cancers in the UK.
Jones B; Pryce PL; Blake PR; Dale RG
Br J Radiol; 1999 Apr; 72(856):371-7. PubMed ID: 10474498
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and morbidity of temporary (125)I brachytherapy in pediatric rhabdomyosarcomas.
Hentz C; Barrett W
Brachytherapy; 2014; 13(2):196-202. PubMed ID: 24246858
[TBL] [Abstract][Full Text] [Related]
35. Urethra low-dose tunnels: validation of and class solution for generating urethra-sparing dose plans using inverse planning simulated annealing for prostate high-dose-rate brachytherapy.
Cunha JA; Pouliot J; Weinberg V; Wang-Chesebro A; Roach M; Hsu IC
Brachytherapy; 2012; 11(5):348-53. PubMed ID: 21937284
[TBL] [Abstract][Full Text] [Related]
36. Treatment of pediatric genitourinary malignancy with interstitial brachytherapy: Peter MacCallum Cancer Institute experience with four cases.
Leung S
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):393-8. PubMed ID: 7836094
[TBL] [Abstract][Full Text] [Related]
37. Brachytherapy versus cystectomy in solitary bladder cancer: a case control, multicentre, East-Netherlands study.
van der Steen-Banasik E; Ploeg M; Witjes JA; van Rey FS; Idema JG; Heijbroek RP; Karthaus HF; Reinders JG; Viddeleer A; Visser AG
Radiother Oncol; 2009 Nov; 93(2):352-7. PubMed ID: 19457565
[TBL] [Abstract][Full Text] [Related]
38. High-dose-rate interstitial brachytherapy for the treatment of penile carcinoma.
Petera J; Odrázka K; Zouhar M; Bedrosová J; Dolezel M
Strahlenther Onkol; 2004 Feb; 180(2):123-5. PubMed ID: 14762666
[TBL] [Abstract][Full Text] [Related]
39. Paediatric brachytherapy. I. The role of brachytherapy in the multidisciplinary therapy of localized cancers.
Plowman PN; Doughty D; Harnett AN
Br J Radiol; 1989 Mar; 62(735):218-22. PubMed ID: 2702378
[TBL] [Abstract][Full Text] [Related]
40. [Brachytherapy for prostate cancer: high dose rate or low-dose rate?].
Cosset JM; Haie-Meder C
Cancer Radiother; 2005 Dec; 9(8):610-9. PubMed ID: 16226473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
